Limited Effectiveness of IL-17 Inhibitors for Anti-TNF-Induced Psoriasis in Hidradenitis Suppurativa: A Multicenter Retrospective Study


Por: Bascón, L, Lluch-Galcerá, JJ, Mora-Fernández, V, Verdaguer-Faja, J, Haselgruber, S, Molina-Leyva, A, Sin-Soler, M, Garbayo-Salmons, P, Mercader-Salvans, J, Araya, VL, Fernández-Crehuet, P, Parra-Navarro, L, Martin-Ezquerra, G, Martin-Poch, A, Carrascosa, JM, Sampayo-Cordero, M, Romaní, J and Vidal, AG

Publicada: 14 abr 2026 Ahead of Print: 1 abr 2026
Resumen:
Background Paradoxical psoriasis (PP) is a known adverse event of anti-tumor necrosis factor (anti-TNF) agents in hidradenitis suppurativa (HS), yet evidence regarding its management remains limited. The objective was to assess the effectiveness of interleukin-17 inhibitors (IL-17i) in treating anti-TNF-induced PP in patients with HS. Methods This multicenter retrospective study included 40 adults with HS who developed PP during anti-TNF therapy and were subsequently treated with IL-17i. Outcomes for PP were measured using the Physician's Global Assessment (PGA); HS severity was evaluated using the International Hidradenitis Suppurativa Severity Score System (IHS4) and Hurley scores. Paired comparisons were performed using the Wilcoxon signed-rank or McNemar's test, as appropriate. Multivariate analysis was performed using LASSO-regularized logistic regression. Missing data were managed by multiple imputation. Results Of the patients, 27.5% achieved a clinically meaningful PP response, while 45% experienced worsening. Female sex, older age at HS onset, and prior exposure to secukinumab were associated with nonresponse. Conversely, HS severity improved significantly in 70% of patients (p < 0.001). Conclusions IL-17i showed limited effectiveness for anti-TNF-induced PP in HS, though improvement in hidradenitis was observed.

Filiaciones:
Bascón, L:
 Hosp Gen Granollers, Dept Dermatol, Barcelona, Spain

Lluch-Galcerá, JJ:
 Hosp Gen Granollers, Dept Dermatol, Barcelona, Spain

 Univ Autonoma Barcelona, Dept Med, Barcelona, Spain

Mora-Fernández, V:
 Hosp Univ Germans Trias i Pujol, Dept Dermatol, IGTP, Barcelona, Spain

Verdaguer-Faja, J:
 Hosp Univ Germans Trias i Pujol, Dept Dermatol, IGTP, Barcelona, Spain

Haselgruber, S:
 Hosp Univ Virgen de Las Nieves Ibs, Granada, Spain

 Univ Granada, Dept Dermatol, Ibs, Granada, Spain

Molina-Leyva, A:
 Hosp Univ Virgen de Las Nieves Ibs, Granada, Spain

 Univ Granada, Dept Dermatol, Ibs, Granada, Spain

Sin-Soler, M:
 Hosp Univ Parc Tauli, Dept Dermatol, Barcelona, Spain

Garbayo-Salmons, P:
 Hosp Univ Parc Tauli, Dept Dermatol, Barcelona, Spain

Mercader-Salvans, J:
 Hosp Univ Canarias, Dept Dermatol, Tenerife, Spain

Araya, VL:
 Hosp Univ Canarias, Dept Dermatol, Tenerife, Spain

Fernández-Crehuet, P:
 Hosp Univ Reina Sofia, Dept Dermatol, Cordoba, Spain

 Maimonides Inst Biomed Res Cordoba IMIB, Cordoba, Spain

Parra-Navarro, L:
 Hosp del Mar, Dept Dermatol, Parc Salut del Mar, Barcelona, Spain

Martin-Ezquerra, G:
 Hosp del Mar, Dept Dermatol, Parc Salut del Mar, Barcelona, Spain

Martin-Poch, A:
 Hosp Univ Sagrat Cor, Dept Dermatol, Grp Quironsalud, Barcelona, Spain

:
 Univ Autonoma Barcelona, Dept Med, Barcelona, Spain

 Hosp Univ Germans Trias i Pujol, Dept Dermatol, IGTP, Barcelona, Spain

Sampayo-Cordero, M:
 Hosp Gen Granollers, Dept Res & Innovat, Granollers, Spain

Romaní, J:
 Hosp Gen Granollers, Dept Dermatol, Barcelona, Spain

Vidal, AG:
 Hosp Gen Granollers, Dept Dermatol, Barcelona, Spain

 Univ Int Catalunya, Barcelona, Spain
ISSN: 13654632





International Journal of Dermatology
Editorial
Blackwell Publishing Inc., 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, Reino Unido
Tipo de documento: Article
Volumen: Número:
Páginas:
WOS Id: 001740258400001
ID de PubMed: 41981919

MÉTRICAS